Published Papers & Misc - MORI MASAAKI

Division display  101 - 120 of about 646 ／  All the affair displays >>

  1. 森, 雅亮. 移行期患者におけるリウマチ診療の展望と問題点 リウマチ科. 2019; 61 (1): 99-104.

  2. 森, 雅亮. 炎症性疾患に対する生物学的製剤の応用性 小児科. 2019; 60 (8): 1173-1181.

  3. 森, 雅亮. 【膠原病診療update-診断・治療の最新知見-】小児の膠原病 日本臨床. 2019; 77 (3): 408-413.

  4. 森, 雅亮. 【全身性疾患と腎update】(第1章)膠原病、血管炎、自己免疫疾患　IgA血管炎・リウマチ専門医の視点より 腎と透析. 2019; 86 (増刊): 106-108.

  5. 森, 雅亮. 【小児リウマチ性疾患の診療〜これまでのエビデンスに基づく最近の知見〜】小児リウマチ性疾患の移行期医療 Pharma Medica. 2019; 37 (7): 69-73.

  6. 森, 雅亮. 【血液浄化療法2019】小児の血液浄化　川崎病 腎と透析. 2019; 87 (3): 492-497.

  7. 毛利, 万里子 and 森, 雅亮. 【小児科医に必要な免疫の知識】免疫関連分子を標的とした生物学的製剤update 小児内科. 2019; 51 (8): 1205-1208.

  8. Okamoto, N; Shabana, K; Nakagishi, Y; Nishimura, K; Mizuta, M; Okura, Y; Shimizu, M; Wakiguchi, H; Yasumura, J; Mori, M. Methotrexate Polyglutamates As an Evaluation Tool for Appropriate Dosage of Oral Methotrexate Administration in Pediatric Patients ARTHRITIS & RHEUMATOLOGY. 2018.09; 70

  9. Mori Masaaki. 小児のリウマチ性疾患　長期予後の改善と成人への過渡期に関するレビュー(Pediatric rheumatic diseases: a review regarding the improvement of long-term prognosis and the transition to adults) Immunological Medicine. 2018.04; 41 (1): 2-5. ( ichushi )

  10. 木村, 弥生 and 柳町, 昌克 and 森, 雅亮 and 平野, 久. 【川崎病アップデート〜病因・病態論の推移と展望〜】プロテオーム解析による新規バイオマーカー探索　川崎病関連タンパク質の発見 アレルギー・免疫. 2018; 25 (11): 1444-1450.

  11. Kawakami, C. and Sato, A. and Sumita, H. and Isozaki, A. and Shimizu, H. and Kanetaka, T. and Maehara, K. and Ao, K. and Nariai, A. and Takeshita, F. and Kizu, R. and Mori, M.. Fever Responses Are Enhanced with Advancing Age during Respiratory Syncytial Virus Infection among Children under 24 Months Old Tohoku J Exp Med. 2018; 245 (3): 217-222.

  12. Mori, M. and Hara, T. and Kikuchi, M. and Shimizu, H. and Miyamoto, T. and Iwashima, S. and Oonishi, T. and Hashimoto, K. and Kobayashi, N. and Waki, K. and Suzuki, Y. and Otsubo, Y. and Yamada, H. and Ishikawa, C. and Kato, T. and Fuse, S.. Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial Sci Rep. 2018; 8 (1): 1994.

  13. Mori, M.. Pediatric rheumatic diseases: a review regarding the improvement of long-term prognosis and the transition to adults Immunol Med. 2018; 41 (1): 2-5.

  14. Matsui, T. and Matsumoto, T. and Hirano, F. and Tokunaga, F. and Okamoto, K. and Tohma, S. and Morio, T. and Kohsaka, H. and Mori, M.. Survey of the awareness of adult rheumatologists regarding transitional care for patients with juvenile idiopathic arthritis in Japan Mod Rheumatol. 2018; 28 (6): 981-985.

  15. Kawakami, C. and Sato, A. and Sumita, H. and Isozaki, A. and Shimizu, H. and Kanetaka, T. and Maehara, K. and Ao, K. and Nariai, A. and Takeshita, F. and Kizu, R. and Mori, M.. Fever Responses Are Enhanced with Advancing Age during Respiratory Syncytial Virus Infection among Children under 24 Months Old Tohoku J Exp Med. 2018; 245 (3): 217-222.

  16. Shimizu, H. and Seki, K. and Shiga, K. and Nakayama, T. and Mori, M.. Safety and efficacy of DTaP-IPV vaccine use in healthcare workers for prevention of pertussis Vaccine. 2018; 36 (40): 5935-5939.

  17. Tamura, D. and Inoue, S. and Kawahara, Y. and Mori, M. and Yamagata, T.. Hypercytokinemia with hemophagocytic syndrome due to human metapneumovirus Pediatr Int. 2018; 60 (10): 974-976.

  18. Shimizu, M. and Mizuta, M. and Yasumi, T. and Iwata, N. and Okura, Y. and Kinjo, N. and Umebayashi, H. and Kubota, T. and Nakagishi, Y. and Nishimura, K. and Yashiro, M. and Yasumura, J. and Yamazaki, K. and Wakiguchi, H. and Okamoto, N. and Mori, M.. Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis Arthritis Care Res (Hoboken). 2018; 70 (9): 1412-1415.

  19. Yokoyama, K. and Mori, M. and Yoshida, A.. Mycophenolate mofetil therapy for two cases of antiphospholipid antibody-associated chorea Mod Rheumatol. 2018; 28 (4): 709-711.

  20. Mori, M. and Nakagawa, M. and Tsuchida, N. and Kawada, K. and Sato, J. and Sakiyama, M. and Hirano, S. and Sato, K. and Nakamura, H.. Proposal for the development of biologics in pediatric rheumatology Pediatr Int. 2018; 60 (2): 108-114.

< PREV - NEXT >

To the head of this page.▲